This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: Lee-Lian Kim: Innovator in Anti-TNF Antibody Treatments
Introduction
Lee-Lian Kim is a notable inventor based in North Wales, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments for autoimmune diseases. With a total of 4 patents, his work focuses on innovative therapies that utilize anti-TNF antibodies.
Latest Patents
Among his latest patents, Lee-Lian Kim has developed compositions and methods for the treatment of active Ankylosing Spondylitis. This invention involves anti-TNF antibodies that include a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37. These compositions are designed for safe and effective treatment of active Ankylosing Spondylitis (AS). Additionally, he has worked on similar compositions and methods for the treatment of active Psoriatic Arthritis (PsA), further showcasing his expertise in this area.
Career Highlights
Lee-Lian Kim is currently associated with Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating therapies that improve the quality of life for patients suffering from chronic inflammatory conditions.
Collaborations
Some of his notable coworkers include Diane Deborah Harrison and Elizabeth C Hsia. Their collaborative efforts contribute to the innovative environment at Janssen Biotech, Inc., fostering advancements in medical treatments.
Conclusion
Lee-Lian Kim's contributions to the field of biotechnology, particularly through his patents on anti-TNF antibodies, highlight his role as a leading inventor in the treatment of autoimmune diseases. His ongoing work promises to bring further advancements in therapeutic options for patients.